L'Oréal's Dermatological Beauty division grew like-for-like sales by 13.9 percent in Q3 2026, tying with Professional Products as the company's fastest-growing segment. The three billionaire brands within the division, La Roche-Posay, CeraVe and SkinCeuticals, each posted double-digit growth.
Puig acquired the remaining 50 percent of Isdin for 1.2 billion euros on September 14, betting that dermocosmetics will be skin care's fastest-growing category in the years ahead. The group's Uriage brand delivered double-digit gains in the quarter. At Beiersdorf, the Derma segment registered 10.6 percent organic sales growth, driven by Eucerin and Aquaphor. Eucerin launched a new acne solution using the patented ingredient TopiC.A in the period.
China returned to growth for multiple beauty companies. The Estée Lauder Cos. reported 9 percent sales growth in China after a difficult few years there. CEO Stéphane de La Faverie called the market "healthy" and described it as a mature market where the company is gaining share. Coty saw net revenues in Asia-Pacific increase by $19.4 million year-over-year, driven by higher sales in China, Southeast Asia and the Asia Travel Retail channel. L'Oréal noted China comprises more than two-thirds of its North Asia business, with the market growing between 2 and 3 percent at the nine-month mark. Interparfums saw Asia-Pacific gains of close to 32 percent in the quarter and 8 percent year-to-date, boosted by China. Procter and Gamble reported 8 percent organic sales growth in Greater China, aided by SK-II.
Multiple beauty makers raised 2026 and 2027 guidance. E.l.f. Beauty lifted its 2027 net sales outlook to between $2 billion and $2.02 billion from $1.93 billion to $1.96 billion, and adjusted net income guidance to between $231 million and $233 million from $212 million to $215 million. The Estée Lauder Cos. raised its fiscal 2027 organic net sales growth guidance to 4 to 5.5 percent from 3 to 5 percent, and adjusted diluted net earnings per share to $3.20 to $3.45 from $3.10 to $3.35. Galderma increased its 2026 full-year net sales guidance to 22.5 to 23.5 percent on-year growth at constant currency versus 19 to 21 percent. Unilever projected at least 3 percent underlying volume growth for 2026.
Fragrance surged at The Estée Lauder Cos., with sales up 20 percent in Q3, driven by double-digit growth at Le Labo, Tom Ford, Jo Malone London, Kilian Paris and the Estée Lauder brand. L'Oréal's fragrance business grew by close to double digits year-to-date in October. Yves Saint Laurent's Libre ranks first worldwide, and Lancôme's La Vie Est Belle drives growth. L'Oréal estimates the worldwide fragrance market is growing by midsingle digits.